Lanean...
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation
The metabolic syndrome (MetS) is an escalating problem worldwide, causing left ventricular stiffening, an early characteristic of diastolic dysfunction for which no treatment exists. As diastolic dysfunction and stiffening in MetS patients are associated with increased circulating dipeptidyl peptida...
Gorde:
| Argitaratua izan da: | J Cell Mol Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7812306/ https://ncbi.nlm.nih.gov/pubmed/33295687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16122 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|